Po‐Han Chen

3.8k total citations
92 papers, 2.8k citations indexed

About

Po‐Han Chen is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Po‐Han Chen has authored 92 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 13 papers in Cell Biology and 12 papers in Oncology. Recurrent topics in Po‐Han Chen's work include RNA Research and Splicing (8 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer-related gene regulation (6 papers). Po‐Han Chen is often cited by papers focused on RNA Research and Splicing (8 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer-related gene regulation (6 papers). Po‐Han Chen collaborates with scholars based in Taiwan, United States and China. Po‐Han Chen's co-authors include Xiaolin He, Jen‐Tsan Chi, Xiaohong Chen, Wen‐Hsuan Yang, Chao‐Chieh Lin, Jianli Wu, Chien‐Kuang Cornelia Ding, Y. H. Kao, Yitong Xu and Cheng‐I Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Genes & Development.

In The Last Decade

Po‐Han Chen

91 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Po‐Han Chen Taiwan 29 1.5k 555 477 306 301 92 2.8k
Wei Song China 28 1.8k 1.2× 594 1.1× 554 1.2× 255 0.8× 324 1.1× 148 3.3k
Xiao Zhang China 35 2.1k 1.4× 570 1.0× 797 1.7× 290 0.9× 364 1.2× 183 4.0k
Chen Li China 31 1.6k 1.1× 562 1.0× 453 0.9× 493 1.6× 515 1.7× 201 3.2k
Peng Zhang China 31 1.4k 0.9× 541 1.0× 497 1.0× 363 1.2× 519 1.7× 203 3.3k
Yao Lin China 31 1.8k 1.2× 268 0.5× 383 0.8× 277 0.9× 522 1.7× 168 3.5k
Tao Yu China 28 1.3k 0.9× 342 0.6× 546 1.1× 306 1.0× 587 2.0× 114 3.0k
Zhenyu Jia United States 31 1.3k 0.8× 380 0.7× 618 1.3× 231 0.8× 311 1.0× 152 2.7k
Ping Gu China 34 1.5k 1.0× 490 0.9× 688 1.4× 440 1.4× 472 1.6× 140 4.0k
Xiaonan Wang China 27 1.8k 1.1× 675 1.2× 470 1.0× 574 1.9× 689 2.3× 151 3.8k
Weidong Xu China 23 1.1k 0.7× 234 0.4× 308 0.6× 228 0.7× 317 1.1× 102 2.4k

Countries citing papers authored by Po‐Han Chen

Since Specialization
Citations

This map shows the geographic impact of Po‐Han Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po‐Han Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po‐Han Chen more than expected).

Fields of papers citing papers by Po‐Han Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po‐Han Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po‐Han Chen. The network helps show where Po‐Han Chen may publish in the future.

Co-authorship network of co-authors of Po‐Han Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Po‐Han Chen. A scholar is included among the top collaborators of Po‐Han Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po‐Han Chen. Po‐Han Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Po‐Han, et al.. (2025). A Novel Framework for Solar Irradiance Prediction Integrating Signal Decomposition With Hybrid Time-Series Models. IEEE Access. 13. 123414–123428. 1 indexed citations
2.
Chen, Po‐Han, et al.. (2024). Finding Your CAR. American Journal Of Pathology. 194(8). 1409–1423. 1 indexed citations
3.
Hu, Zhenyi, Po‐Han Chen, Jacques Saarbach, et al.. (2024). EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signaling. Science Advances. 10(13). eadj7251–eadj7251. 18 indexed citations
4.
Kao, Y. H., Yu‐Chun Lin, Po‐Han Chen, et al.. (2023). Mesenchymal Stem Cell-Derived Exosomes Mitigate Acute Murine LiverInjury via Ets-1 and Heme Oxygenase-1 Up-regulation. Current Stem Cell Research & Therapy. 19(6). 906–918. 4 indexed citations
5.
Kovach, Alexander R., David G. Kirsch, Rex C. Bentley, et al.. (2022). Identification and targeting of a HES1‐YAP1‐CDKN1C functional interaction in fusion‐negative rhabdomyosarcoma. Molecular Oncology. 16(20). 3587–3605. 6 indexed citations
6.
Chen, Po‐Han, Jianli Wu, Yitong Xu, et al.. (2021). Zinc transporter ZIP7 is a novel determinant of ferroptosis. Cell Death and Disease. 12(2). 198–198. 90 indexed citations
7.
Lin, Chao‐Chieh, Wen‐Hsuan Yang, Yi-Tzu Lin, et al.. (2021). DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. Oncogene. 40(11). 2018–2034. 80 indexed citations
8.
Liu, Wen-Chih, Jia-Fwu Shyu, Yuh‐Feng Lin, et al.. (2020). Resveratrol Rescue Indoxyl Sulfate-Induced Deterioration of Osteoblastogenesis via the Aryl Hydrocarbon Receptor /MAPK Pathway. International Journal of Molecular Sciences. 21(20). 7483–7483. 30 indexed citations
10.
Chen, Po‐Han, et al.. (2020). The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics. Biology. 9(8). 187–187. 34 indexed citations
11.
Ding, Chien‐Kuang Cornelia, J.A. Rose, Tianai Sun, et al.. (2020). MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis. Nature Metabolism. 2(3). 270–277. 132 indexed citations
12.
Cheng, Cheng‐I, Huoy‐Rou Chang, Ming‐Hong Tai, et al.. (2020). Hepatoma-derived growth factor enhances osteoblastic transformation of rat aortic vascular smooth muscle cells in vitro. Life Sciences. 256. 117964–117964. 4 indexed citations
13.
Chen, Po‐Han, Jianli Wu, Timothy J. Smith, et al.. (2019). Gigaxonin glycosylation regulates intermediate filament turnover and may impact giant axonal neuropathy etiology or treatment. JCI Insight. 5(1). 11 indexed citations
15.
Chen, Po‐Han, Timothy J. Smith, Jianli Wu, et al.. (2017). Glycosylation of KEAP 1 links nutrient sensing to redox stress signaling. The EMBO Journal. 36(15). 2233–2250. 85 indexed citations
16.
Chen, Po‐Han, Jen‐Tsan Chi, & Michael Boyce. (2017). KEAP1 has a sweet spot: A new connection between intracellular glycosylation and redox stress signaling in cancer cells. Molecular & Cellular Oncology. 4(6). e1361501–e1361501. 8 indexed citations
17.
Chen, Po‐Han, Ming‐Shyan Lin, Tung‐Jung Huang, & Mei‐Yen Chen. (2017). Prevalence of and factors associated with adopting bone health promoting behaviours among people with osteoporosis in Taiwan: a cross-sectional study. BMJ Open. 7(9). e015980–e015980. 12 indexed citations
18.
Bachelder, Robin E., Margaret Kennedy, Po‐Han Chen, et al.. (2015). Syngeneic Murine Ovarian Cancer Model Reveals That Ascites Enriches for Ovarian Cancer Stem-Like Cells Expressing Membrane GRP78. Molecular Cancer Therapeutics. 14(3). 747–756. 34 indexed citations
19.
Crose, Lisa E.S., et al.. (2015). Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3–FOXO1-Positive Alveolar Rhabdomyosarcoma. Clinical Cancer Research. 21(21). 4868–4880. 20 indexed citations
20.
Hsiao, Chih‐Cheng, Po‐Han Chen, Cheng‐I Cheng, et al.. (2015). Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells. Cancer Letters. 368(1). 144–152. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026